Radiopharm Theranostics Limited

Radiopharm Theranostics Limitedverified

RADX

Price:

$4.59

Market Cap:

$8.91M

Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It develops RAD 204, a programmed death-ligand 1 (PD-L1) for the treatment of non-small cell lung cancer (NSCLC); RAD 202, a human epidermal growth factor receptor 2 (HER2) to treat breast cancer and other solid tumors; and RAD 301, a diagnostic radiopharmaceutical targeting avß6 integrin in pancreatic ductal adenocarcinoma patients. The company also develops RAD 302, an avß6-integrin targeting agent for the treatment of multiple cancer types; RAD 101 and RAD 102 for brain metastases; RAD 402 to treat advanced prosta...[Read more]

Industry

Biotechnology

IPO Date

2024-12-05

Stock Exchange

NASDAQ

Ticker

RADX

The ROE as of December 2025 (TTM) for Radiopharm Theranostics Limited (RADX) is 0%

According to Radiopharm Theranostics Limited’s latest financial reports and current stock price. The company's current ROE is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Radiopharm Theranostics Limited (RADX) Historical ROE (quarterly & annually)

How has RADX ROE performed in the past?

The mean historical ROE of Radiopharm Theranostics Limited over the last ten years is -95.57%. The current 0% ROE has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), RADX's ROE was at its highest in in the June 2022 quarter at 0%. The ROE was at its lowest in in the June 2022 quarter at 0%.

Quarterly (TTM)
Annual

Average

-95.57%

Median

-81.79%

Minimum

-170.50%

Maximum

-48.19%

Radiopharm Theranostics Limited (RADX) ROE by Quarter and Year

Discovering the peaks and valleys of Radiopharm Theranostics Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 118.65%

Maximum Annual ROE = -48.19%

Minimum Annual Increase = -49.79%

Minimum Annual ROE = -170.50%

Quarterly (TTM)
Annual
YearROEChange
2025-85.60%-49.79%
2024-170.50%118.65%
2023-77.98%61.83%

Radiopharm Theranostics Limited (RADX) Average ROE

How has RADX ROE performed in the past?

The current ROE of Radiopharm Theranostics Limited (RADX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-111.36%

5-year avg

-95.57%

10-year avg

-95.57%

Radiopharm Theranostics Limited (RADX) ROE vs. Peers

How is RADX’s ROE compared to its peers?

Radiopharm Theranostics Limited’s ROE is greater than Alaunos Therapeutics, Inc. (-167.97%), greater than Impact BioMedical Inc. (-528.69%), greater than Quoin Pharmaceuticals, Ltd. (-210.51%), less than NovaBay Pharmaceuticals, Inc. (117.09%), less than Brainstorm Cell Therapeutics Inc. (223.86%), greater than Cardio Diagnostics Holdings, Inc. (-72.79%), greater than Addex Therapeutics Ltd (-66.77%), greater than Matinas BioPharma Holdings, Inc. (-249.82%), greater than Pasithea Therapeutics Corp. (-99.53%), greater than Cyclerion Therapeutics, Inc. (-24.61%),

Build a custom stock screener for Radiopharm Theranostics Limited (RADX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Radiopharm Theranostics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Radiopharm Theranostics Limited (RADX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Radiopharm Theranostics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Radiopharm Theranostics Limited's ROE?

How is the ROE calculated for Radiopharm Theranostics Limited (RADX)?

What is the highest ROE for Radiopharm Theranostics Limited (RADX)?

What is the 3-year average ROE for Radiopharm Theranostics Limited (RADX)?

What is the 5-year average ROE for Radiopharm Theranostics Limited (RADX)?

How does the current ROE for Radiopharm Theranostics Limited (RADX) compare to its historical average?